510(k) Report

510(k) · Cleared

Cleared

Millipede System

K262399510(k) SpecialCleared Aug 12, 202629-day reviewClass II21 CFR 870.1250

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Perfuze, Ltd. · NRY Catheter, Thrombus Retriever

Cleared on Aug 12, 2026 as substantially equivalent to K253590 (Perfuze, Ltd., 2026) after a 29-day review. Its family tree reaches back 15 generations to 2001.

Decided
Aug 12, 2026
Review
29 days
Class
Class II
Product code
NRY
Recalls
None
Predicates
1

Its longest line of descent runs back 15 generations to K003410 (2001). 18 ancestors in all, the oldest K003086 (2001). No later device cites it as a predicate yet.

  1. Root · 15 generations backK003410 Concentric Retriever, Model 90030Concentric Medical, Inc. · 2001 · Recalled
  2. 11 generations between
  3. 3 generations backK191768 AXS Vecta Aspiration SystemStryker Neurovascular · 2019
  4. 2 generations backK243601 Route 92 Medical HiPoint Reperfusion System and Aspiration Tubing SetRoute 92 Medical, Inc. · 2025
  5. 1 generation backK253590 Millipede SystemPerfuze, Ltd. · 2026
  6. This deviceK262399 Millipede SystemPerfuze, Ltd. · 2026
Show all 15 generations
  1. Root · 15 generations backK003410 Concentric Retriever, Model 90030Concentric Medical, Inc. · 2001 · Recalled
  2. 14 generations backK030476 Modified Concentric Retriever, Model 90037Concentric Medical, Inc. · 2003 · Recalled
  3. 13 generations backK033736 Merci Retriever, Models 90065, 90066Concentric Medical, Inc. · 2004
  4. 12 generations backK072718 Penumbra SystemPenumbra, Inc. · 2007 · Recalled
  5. 11 generations backK100769 Penumbra System Separator Flex (026,032,041,054), Models PSF026…Penumbra, Inc. · 2010
  6. 10 generations backK113163 Penumbra System MaxPenumbra, Inc. · 2011
  7. 9 generations backK142458 Penumbra System ACEPenumbra, Inc. · 2015
  8. 8 generations backK152541 Penumbra System ACE 64 and ACE 68 Reperfusion CathetersPenumbra, Inc. · 2016
  9. 7 generations backK161064 Penumbra System ACE 68 Reperfusion CatheterPenumbra, Inc. · 2016
  10. 6 generations backK172167 Zenith Flex SystemInneuroco, Inc. · 2018 · Recalled
  11. 5 generations backK181354 074 Zenith Flex SystemInneuroco, Inc. · 2018 · Recalled
  12. 4 generations backK190212 AXS Vecta Aspiration SystemStryker Neurovascular · 2019
  13. 3 generations backK191768 AXS Vecta Aspiration SystemStryker Neurovascular · 2019
  14. 2 generations backK243601 Route 92 Medical HiPoint Reperfusion System and Aspiration Tubing SetRoute 92 Medical, Inc. · 2025
  15. 1 generation backK253590 Millipede SystemPerfuze, Ltd. · 2026
  16. This deviceK262399 Millipede SystemPerfuze, Ltd. · 2026
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−15K003410Concentric Retriever, Model 90030Concentric Medical, Inc.20011
−14K030476Modified Concentric Retriever, Model 90037Concentric Medical, Inc.20032
−13K033736Merci Retriever, Models 90065, 90066Concentric Medical, Inc.2004—
−12K072718Penumbra SystemPenumbra, Inc.20071
−11K100769Penumbra System Separator Flex (026,032,041,054), Models PSF026, PSF032…Penumbra, Inc.2010—
−10K113163Penumbra System MaxPenumbra, Inc.2011—
−9K142458Penumbra System ACEPenumbra, Inc.2015—
−8K152541Penumbra System ACE 64 and ACE 68 Reperfusion CathetersPenumbra, Inc.2016—
−7K161064Penumbra System ACE 68 Reperfusion CatheterPenumbra, Inc.2016—
−6K172167Zenith Flex SystemInneuroco, Inc.20181
−5K181354074 Zenith Flex SystemInneuroco, Inc.20181
−4K190212AXS Vecta Aspiration SystemStryker Neurovascular2019—
−3K191768AXS Vecta Aspiration SystemStryker Neurovascular2019—
−2K243601Route 92 Medical HiPoint Reperfusion System and Aspiration Tubing SetRoute 92 Medical, Inc.2025—
−1K253590Millipede SystemPerfuze, Ltd.2026—
0 (this device)K262399Millipede SystemPerfuze, Ltd.2026—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110
200910
201410
FIG. 1 — Lineage of K262399, 2001–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in NRY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new NRY device

  1. #1 K232971 APRO 55 Catheter and Alembic Aspiration Tubingscore 18.6 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K253590Millipede System
Summary page 5
….1250 Product Code: NRY Manufacturer: Perfuze Ltd. 510(k) Number: K253590 Reference Device Proprietary Name: Millipede88 Access Catheter Common/Usual Name:…
Perfuze, Ltd.2026—
†K253901Millipede88 Access CatheterPerfuze, Ltd.2026—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 25 years and passes through 6 companies; a new generation was cleared every 1.4 years on median.
  • 5 of the 18 ancestors have a recall of any class.

How does its category compare?

All NRY devices

NRY Catheter, Thrombus Retriever: FDA decisions, review times, recalls and adverse event reports over 20 years. 2026, this device’s year, is highlighted.

FDA decisions per year · NRY

15in 2025

2007: 52008: 22009: 22010: 12011: 22012: 42014: 42015: 62016: 52017: 32018: 112019: 72020: 62021: 92022: 32023: 82024: 82025: 152026 (partial year): 14
2007high 15 (2025) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · NRY

129in 2025

2007: 94 days median2012: 90 days median2014: 140 days median2015: 128 days median2016: 75 days median2017: 185 days median2018: 156 days median2019: 89 days median2020: 125 days median2021: 80 days median2022: 129 days median2023: 112 days median2024: 165 days median2025: 129 days median2026 (partial year): 147 days median
2007high 185 (2017) · low 75 (2016)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · NRY

4in 2020

2010: 12013: 12017: 42020: 4, 4 Class I2026 (partial year): 2
2007high 4 (2017) · low 0 (2007)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · NRY

565in 2025

2007: 132008: 182009: 572010: 2892011: 2632012: 3662013: 4052014: 4282015: 5982016: 4972017: 4322018: 4152019: 6502020: 7032021: 6882022: 5492023: 7112024: 6412025: 565
2007high 711 (2023) · low 13 (2007)2025

MAUDE reports naming product code NRY, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007594013
20082—018
20092—057
20101—1289
20112—0263
20124900366
20130—1405
201441400428
201561280598
20165750497
201731854432
2018111560415
20197890650
202061254 (4)703
20219800688
202231290549
202381120711
202481650641
2025151290565
2026141472—

What is it indicated for?

As part of the Millipede System, the Millipede88 Aspiration Catheter with the Perfuze Aspiration Tube Set and a compatible aspiration pump, is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease within the internal carotid artery and middle cerebral artery M1 segment within 8 hours of symptom onset. Patients who are ineligible for intravenous thrombolytic drug therapy…

Read the full statement (190 words)

As part of the Millipede System, the Millipede88 Aspiration Catheter with the Perfuze Aspiration Tube Set and a compatible aspiration pump, is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease within the internal carotid artery and middle cerebral artery M1 segment within 8 hours of symptom onset. Patients who are ineligible for intravenous thrombolytic drug therapy or who have not responded to thrombolytic drug therapy are candidates for treatment.

As part of the Millipede System, the Millipede70 Aspiration Catheter with the Perfuze Aspiration Tube Set and a compatible aspiration pump, is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral – M1 and M2 segments, basilar and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous thrombolytic drug therapy or who have not responded to thrombolytic drug therapy are candidates for treatment.

As part of the Millipede System, the Perfuze Aspiration Tube Set is indicated to connect the Millipede88 or Millipede70 Aspiration Catheter to a compatible aspiration pump.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K262399: Millipede System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K262399

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded Oct 30, 2026
  • Summary read Oct 30, 2026 (extraction version 2d9447fa9ea4)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026